Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23798450.
- Also identified by DOI 10.1002/adma.201301232.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A novel 980 nm laser-driven hydrophobic anticancer drug-delivery platform based on hollow CuS nanoparticles is constructed in this work. The excellent synergistic therapy combining drug treatment and photothermal ablation of cancer cells both in vitro and in vivo is demonstrated, which opens up new opportunities for biological and medical applications.
Medical subject headings
- Antineoplastic Agents
- Camptothecin
- Copper
- Drug Carriers
- Nanoparticles
- Sulfides